Assessing the long-term fiscal consequences attributed to Hepatitis C and the impact of ledipasvir/sofosbuvir combination curative therapies in UK

被引：0
|
作者：
Connolly, Mark [1 ,2 ]
Kotsopoulos, Nikos [2 ]
机构：
[1] Univ Groningen, Pharmacoecon, Groningen, Netherlands
[2] Global Market Access Solut, Hlth Econ, Charlotte, NC USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
97
引用
收藏
页码：53A / 53A
页数：1
相关论文
共 50 条
  • [1] LONG-TERM OUTCOMES OF LEDIPASVIR/SOFOSBUVIR (LDV/ SOF) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (HCV) GENOTYPE 1 PATIENTS IN THE UK
    Guerra, I
    Marie, L.
    Cure, S.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [2] The Efficacy and Safety of Sofosbuvir/Ledipasvir Therapy in Patients on Long-term Hemodialysis with Hepatitis C Virus Infection
    Cavoli, G. Li
    Schillaci, O.
    Zagarrigo, C.
    Servillo, F.
    Cavoli, T. V. Li
    Palmeri, M.
    Rotolo, U.
    [J]. INDIAN JOURNAL OF NEPHROLOGY, 2018, 28 (02) : 175 - +
  • [3] Long term retrospective study on hepatitis C patients treated with ledipasvir/sofosbuvir in a large health maintenance organization
    Chang, Joseph C.
    Kleinman, Nicole
    Pham, Duyen
    Chung, Joanie
    Towner, William J.
    [J]. HEPATOLOGY, 2017, 66 : 619A - 620A
  • [4] Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
    Degertekin, Bulent
    Demir, Mehmet
    Akarca, Ulus S.
    Kani, Haluk Tarik
    Ucbilek, Enver
    Yildirim, Emre
    Guzelbulut, Fatih
    Balkan, Ayhan
    Vatansever, Sezgin
    Danis, Nilay
    Demircan, Melek
    Soylu, Aliye
    Yaras, Serkan
    Kartal, Aysun
    Kefeli, Ayse
    Gunduz, Feyza
    Yalcin, Kendal
    Erarslan, Elife
    Aladag, Murat
    Harputluoglu, Murat
    Ozakyol, Aysegul
    Temel, Tuncer
    Akarsu, Mesut
    Sumer, Hale
    Akin, Mete
    Albayrak, Bulent
    Sen, Ilker
    Alkim, Huseyin
    Uyanikoglu, Ahmet
    Irak, Kader
    Oztaskin, Sinem
    Ugurlu, Cagri Burak
    Gunes, Sevkican
    Gurel, Selim
    Nuriyev, Kenan
    Inci, Ismail
    Kacar, Sabite
    Dincer, Dinc
    Doganay, Levent
    Gokturk, Huseyin Savas
    Mert, Ali
    Cosar, Arif Mansur
    Dursun, Hakan
    Atalay, Roni
    Akbulut, Sabiye
    Balkan, Yasemin
    Koklu, Hayrettin
    Simsek, Halis
    Ozdogan, Osman
    Coban, Mehmet
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31 (12): : 883 - 893
  • [5] ASSESSING THE IMPACT OF TAX EVASION ON LONG-TERM FISCAL IMBALANCE: A SENSITIVITY ANALYSIS APPLICATION
    Mihokova, Lucia
    Drab, Radovan
    Kralik, Andrea
    [J]. PRAGUE ECONOMIC PAPERS, 2018, 27 (03): : 331 - 350
  • [6] LONG-TERM OUTCOMES OF SOFOSBUVIR (SOF) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (CHC) PATIENTS
    Cure, S.
    Guerra, I
    Dusheiko, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A357 - A357
  • [7] Long-term outcomes of sofosbuvir (SOF) for the treatment of chronic hepatitis C infected (CHC) patients
    Cure, Sandrine
    Guerra, Ines
    Granzow, Henrike
    Dusheiko, Geoffrey M.
    [J]. HEPATOLOGY, 2013, 58 : 747A - 747A
  • [8] Assessing the impact of psychoanalyses and long-term psychoanalytic therapies on health care utilization and costs
    Beutel, ME
    Rasting, M
    Stuhr, U
    Rüger, B
    Leuzinger-Bohleber, M
    [J]. PSYCHOTHERAPY RESEARCH, 2004, 14 (02) : 146 - 160
  • [9] LONG-TERM OUTCOMES ASSOCIATED WITH SOFOSBUVIR-BASED REGIMENS FOR TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Tang, H.
    Wu, J.
    Wu, B.
    Xu, X.
    Ye, X.
    Zhang, W.
    [J]. VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [10] long-term follow up of chronic hepatitis C Egyptian patients treated with sofosbuvir/daclatasvir regimen
    Elnoemany, Karim
    Badr, Mohamed
    Elnadry, Mohamed
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 137 - 137
12345